Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3024% below fair value
$2.73+0.13 (+5.00%)
Close on Nov 18, 2026Market cap $156.11MP/E –Yield –
Abeona Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Abeona Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$81.53M. For fiscal 2025 it was -$84.30M. The highest annual figure on record is -$1.00K in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$84.30M | – |
| FY2024 | Dec 31, 2024 | -$58.46M | – |
| FY2023 | Dec 31, 2023 | -$37.34M | – |
| FY2022 | Dec 31, 2022 | -$43.61M | – |
| FY2021 | Dec 31, 2021 | -$69.82M | – |
| FY2020 | Dec 31, 2020 | -$36.36M | – |
| FY2019 | Dec 31, 2019 | -$69.13M | – |
| FY2018 | Dec 31, 2018 | -$48.35M | – |
| FY2017 | Dec 31, 2017 | -$23.52M | – |
| FY2016 | Dec 31, 2016 | -$13.53M | – |
| FY2015 | Dec 31, 2015 | -$10.73M | – |
| FY2014 | Dec 31, 2014 | -$1.61M | – |
| FY2013 | Dec 31, 2013 | -$1.00K | – |
| FY2012 | Dec 31, 2012 | -$3.97M | – |
| FY2011 | Dec 31, 2011 | -$7.65M | – |
| FY2010 | Dec 31, 2010 | -$6.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.98M | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.74M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.11M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$21.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.80M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.17M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.79M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.32M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.96M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.79M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.74M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.55M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.64M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.97M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.37M | – |
| Q3 FY2019 | Sep 30, 2019 | -$19.19M | – |
| Q2 FY2019 | Jun 30, 2019 | -$19.27M | – |
| Q1 FY2019 | Mar 31, 2019 | -$16.30M | – |
| Q4 FY2018 | Dec 31, 2018 | -$17.63M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.70M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.44M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.84M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.99M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.93M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.41M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.14M | – |
See a number that looks wrong?